LBMC Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
LBMC Investment Advisors's LLY Position: Q2 2026 in Review
LBMC Investment Advisors reduced its Eli Lilly (LLY) stake by 51% in Q2 2026, selling an estimated $1.82M and leaving 1,708 shares worth $2.05M. The position accounts for 0.11% of the portfolio, ranked #77.
LBMC Investment Advisors first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.73M in Q4 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- LBMC Investment Advisors held 1,708 shares of Eli Lilly worth $2.05M as of Q2 2026.
- LBMC Investment Advisors sold 1,786 Eli Lilly shares in Q2 2026, an estimated $1.82M.
- Eli Lilly made up 0.11% of LBMC Investment Advisors's portfolio in Q2 2026, its #77 holding.
- LBMC Investment Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- LBMC Investment Advisors's Eli Lilly position peaked at $3.73M in Q4 2025.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on LBMC Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.